SCHD’s 3% Yield Hides a $216,000 Decade-Long Performance Gap Investors Miss
Most SCHD holders track the quarterly payout and call it a win, but a decade of reinvested dividends tells a story the fund's marketing materials never mention. The yield looks safe until you compare the account balance.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Dividend investors are drawn to a simple pitch: a 3% yield, a low fee, and the familiar Schwab brand. Holders of the Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) who sank $300,000 into the fund ten years ago and reinvested every distribution ended August with roughly $1.03 million. That same money in a plain S&P 500 index would have grown to about $1.25 million. That is a gap of more than $216,000, and it did not show up on any monthly statement.
What You Are Actually Paying
Let’s start with the headline fee, because it is the smallest problem. SCHD maintains an expense ratio of 0.06%, or about $6 per year on every $10,000 invested. The Vanguard S&P 500 ETF (NYSEARCA:VOO) charges 0.03%, or roughly $3 per $10,000. On a $300,000 position, that fee delta compounds to a few thousand dollars over a decade. Annoying, but not a significant problem.
The real bill is opportunity cost. From the completed month-end window of August 31, 2016 through August 31, 2026, SCHD returned 244.45% on a dividend-reinvested basis. VOO returned 316.54% over the identical window. That is a spread of about 72 percentage points. On a $300,000 investment, the gap for a decade holder is close to $216,000. Chasing a 3.08% trailing yield results in a significant foregone total return.
Costs the Factsheet Does Not Highlight
SCHD tracks the Dow Jones U.S. Dividend 100 Index, which screens for consistent payers with strong balance sheets. That rule mechanically excludes most of the megacap growth names that carried the S&P 500 over the past decade. Look at what SCHD does hold: Merck at 4.76% of net assets, Amgen at 4.70%, Abbott Laboratories at 4.68%, Coca-Cola at 4.16%, Chevron at 4.01%, and Verizon at 3.96%. Energy, telecoms, healthcare, and consumer staples dominate SCHD’s holdings. NVIDIA, Microsoft, Apple, and Alphabet are absent or negligible. That composition is the source of the total-return gap.
Additionally, there is a second quiet cost showing up in the distribution data. The latest quarterly payout was $0.2525, down from $0.2569 the prior quarter. The income the fund is marketed on is currently shrinking at a per-share level (a shrinking payout is one of the warning signs we cataloged in a free guide to dividend traps). Holders who bought SCHD as a bond substitute are getting less cash while also giving up some broad-market upside.
Cheaper Mirrors With Real Trade-Offs
If broad U.S. equity exposure is the goal, VOO at 0.03% has delivered stronger returns. That said, if a dividend tilt is non-negotiable, the Vanguard Dividend Appreciation ETF (NYSEARCA:VIG) and iShares Core Dividend Growth ETF (NYSEARCA:DGRO) screen for dividend growth rather than raw yield, which keeps more technology and quality-growth exposure in the basket. Yield is lower, but total-return history has been closer to the broad market. The trade-off is clear: less current cash, more participation in whatever is actually driving the index.
What This Means for You
SCHD serves a specific purpose and its fee is competitive. The right question is whether the roughly 3.08% trailing yield is worth a rules-based screen that has, over the last decade ending August 31, 2026, sat out the parts of the market that produced most of the gains. Look at your own statement, compare the ten-year adjusted return to a plain index fund, and decide whether the distribution yield adequately compensates for the total return the dividend screen excludes.
Contact [email protected] for any questions or corrections.








